CompletedNot Applicable

Hormone Evaluation in Artificial Reproductive Technology

Poland, Sweden810 participantsStarted 2016-09

Plain-language summary

The aim is to be able to predict the hormonal response according to gonadotropin receptor genotype and hormone type used for treatment of women undergoing in vitro fertilization or egg donation. Outcome will be measured as pregnancy success, live born babies and unwanted side effects.

Who can participate

Age range25 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Normal ovulatory cycles 26-32 days * First and second IVF treatment * Indication for IVF is male factor, tubal factor or unexplained infertility * Medical indication for IVF; \>12 months unprotected intercourse Exclusion Criteria: * Anti Müllerian Hormone \<5pmol or cycle day 2-3 FSH \>12 * Endometriosis * polycystic ovarian syndrome * pre ovarian failure * smoking * male age more than 56.

What they're measuring

Pregnancy

Timeframe: up to 12 months after treatment

Trial details

NCT IDNCT03737253

SponsorLund University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Female Infertility trials